HealthcareServices

Global Nanotechnology In Cancer Treatment Market 2026–2030: Forecast Insights for Business Planning

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the nanotechnology in cancer treatment market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Nanotechnology In Cancer Treatment Market size between 2026 and 2035?

The nanotechnology in cancer treatment market size has experienced significant expansion in recent years. It is projected to increase from $159.07 billion in 2025 to $183.23 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.2%. This growth observed in the past can be ascribed to factors such as rising cancer incidence rates, continuous progress in nanomaterial engineering, increased funding for oncology research, stronger collaboration between pharmaceutical firms and research bodies, and the initial clinical triumphs of nano-based therapies.

The market for nanotechnology in cancer treatment is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $319.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.9%. This growth during the projection period is driven by factors such as the increasing embrace of personalized cancer treatment methods, growing investments in nanomedicine research, the widening scope of clinical trials incorporating nanotechnology, an escalating emphasis on minimally invasive cancer therapies, and innovations in nano-enabled diagnostics. Key trends expected during this period involve the increasing creation of nanoparticle-based drug delivery systems, the greater acceptance of targeted cancer therapies, an expanding utilization of multifunctional nanomaterials, the broadening of personalized oncology treatments, and a heightened emphasis on mitigating the adverse effects of chemotherapy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27357&type=smp

Which Drivers Are Impacting Market Performance In The Nanotechnology In Cancer Treatment Market?

An increasing need for targeted therapies is anticipated to fuel the expansion of nanotechnology in the cancer treatment market. These therapies are defined as cancer treatments designed to pinpoint and act on specific molecular markers or biological pathways crucial for tumor development. The heightened demand for targeted therapies stems from their capacity to accurately target cancer cells, thereby limiting harm to healthy tissues and mitigating adverse effects. In cancer treatment, nanotechnology boosts targeted therapies by facilitating the accurate delivery of medications straight to malignant cells, thereby boosting their efficacy and safeguarding healthy tissues. For example, a report from the American Society of Gene & Cell Therapy (ASGCT), a professional membership organization based in the US, indicated in July 2023 that while 247 gene therapies were in Phase II at the close of Q1 2023, this figure saw a 5% increase, reaching 260 by the end of Q2 2023. Consequently, the expanding requirement for targeted therapies is propelling the growth of nanotechnology in the cancer treatment market.

What Segment Types Are Examined In The Nanotechnology In Cancer Treatment Market?

The nanotechnology in cancer treatment market covered in this report is segmented –

1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles

2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance

3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types

4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems

5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)

Subsegments:

1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes

2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers

3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles

Which Trends Are Influencing The Performance And Direction Of The Nanotechnology In Cancer Treatment Market?

Major companies within the nanotechnology in cancer treatment market are concentrating on developing sophisticated therapies, such as immunotherapy nano formulations, to improve immune system targeting and minimize adverse effects for cancer patients. This method employs nanotechnology to deliver immune-based treatments directly to specific target sites, thereby boosting treatment precision while also enhancing drug stability, bioavailability, and the activation of the immune response. As an illustration, in December 2023, Cello Therapeutics, a US-based biotechnology company, launched CE120, a broad-spectrum therapeutic cancer nano vaccine that successfully obtained Food and Drug Administration clearance. This therapy marks the first clinical use of platelet membrane-coated nanoparticles for treating solid tumors. CE120 integrates targeted drug delivery with immune system activation, aiming to destroy tumors and prevent recurrence. Its distinctive nanotechnology platform significantly improves both therapeutic precision and the immune response, positioning CE120 as a pioneering nanomedicine in cancer treatment.

Who Are The Primary Competitors In The Global Nanotechnology In Cancer Treatment Market?

Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., Selecta Biosciences Inc., Bind Therapeutics Inc., BlueWillow Biologics Inc., Nanobiomed Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/nanotechnology-in-cancer-treatment-global-market-report

Which Regions Are Poised For Strategic Growth In The Nanotechnology In Cancer Treatment Market?

North America was the largest region in the nanotechnology in cancer treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanotechnology in cancer treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Nanotechnology In Cancer Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27357&type=smp

Browse Through More Reports Similar to the Global Nanotechnology In Cancer Treatment Market 2026, By The Business Research Company

Biosurgery Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

Core Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/core-materials-global-market-report

Biomaterials Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795